Personalized medicine and preventive health care: juxtaposing health policy and clinical practice

References

• Ackerman, J. P., Bartos, D. C., Kapplinger, J. D., Tester, D. J., Delisle, B. P., & Ackerman, M. J. (2016). The promise and peril of precision medicine: Phenotyping still matters most. Mayo Clinic Proceedings, 90(11), 1606–1616.
   Google Scholar
• Adams, V., ., Murphy, M., & Clarke, A. E. (2009). Anticipation: Technoscience, life, affect, temporality. Subjectivity, 28(1), 246–265.
   Google Scholar
• Australian Genomics Health Alliance. (2019). Integrating genomics into health care. Retrieved from https://www.australiangenomics.org.au/about-us/australian-genomics/
   Google Scholar
• Borup, M., Brown, N., Konrad, K., & van Lente, H. (2006). The sociology of expectations in science and technology. Technology Analysis & Strategic Management, 18(3/4), 285–298.
   Web of Science ®Google Scholar
• Danish Cardiac Society. (2013). Hereditary heart diseases. DCS instruction 2013, number 1. Copenhagen: Author.
   Google Scholar
• Dickenson, H., van Beers, B., & Sterckx, S. (2018). Introduction. In D. Dickenson, B. van Beers, & S. Sterckx (Eds.), Personalized medicine, individual choice and the common good (pp. 1–16). Cambridge: Cambridge University Press.
   Google Scholar
• European Science Foundation. (2012). Personalized medicine for the European citizen. Towards more precise medicine for the diagnosis, treatment and prevention of disease (iPM). Strasbourg: Author.
   Google Scholar
• Gjødsbøl, I. (2019). Personlig medicin – Forebyggelse i politik og praksis [Personalized medicine – prevention in policy and practice]. In S. Glasdam & H. B. Boelsbjerg (Eds.), Folkesundhed – Bag om intentioner og strategier [Personalized medicine – beyond intentions and strategies] (pp. 115–126). Copenhagen: Gads Forlag.
   Google Scholar
• Green, S., Carusi, A., & Hoeyer, K. (2019). Plastic diagnostics: The remaking of disease and evidence in personalized medicine. Social Science & Medicine. doi:10.1016/j.socscimed.2019.05.023
   Google Scholar
• Hoeyer, K. (2019). Data a promise: Reconfiguring Danish public health through personalized medicine. Social Studies of Science, 49(4), 531–555.
   PubMed Web of Science ®Google Scholar
• Hood, L., & Flores, M. (2012). A personal view on systems medicine and the emergence of proactive P4 medicine: Predictive, preventive, personalized and participatory. New Biotechnology, 29(6), 613–624.
   PubMed Web of Science ®Google Scholar
• Juengst, E., McGowan, M. L., Fishman, J. R., & Settersten, R. A., Jr. (2016). From ”personalized” to ”precision” medicine: The ethical and social implications of rhetorical reform in genomic medicine. The Hasting Center Report, 46(5), 21–33.
   PubMed Web of Science ®Google Scholar
• Khoury, M. J., Iademarco, M. F., & Riley, W. T. (2016). Precision public health for the era of precision medicine. American Journal of Preventive Medicine, 50(3), 398–401.
   PubMed Web of Science ®Google Scholar
• Mattingly, C. (2010). The paradox of hope. Journeys through a clinical borderland. Berkeley and Los Angeles: University of California Press.
   Google Scholar
• Ministry of Health (Denmark). (2016). Kortlægning af international erfaringer med personlig medicin [Mapping of international experiences with personalized medicine]. Retrieved from https://www.sum.dk/Temaer/Personlig-medicin/~/media/Filer%20-%20Publikationer_i_pdf/2016/Personlig-medicin/PA_Personlig_Medicin_Final.ashx
   Google Scholar
• Ministry of Health (Denmark). (2018a). 1 milliard kroner på vej til skræddersyet behandling til danske patienter [1 billion DKK to tailored treatment to Danish patients]. Press release 2018, December 21. Retrieved from https://sum.dk/Aktuelt/Nyheder/Medicin/2018/December/1-mia-kr-paa-vej-til-skraeddersyet-behandling-til-danske-patienter.aspx
   Google Scholar
• Ministry of Health (Denmark). (2018b). Op mod 60.000 genetiske analyser af danske patienter på vej [Up to 60.000 genetic analyses of Danish patients under way]. 2018, May 1. Retrieved from https://www.sum.dk/Aktuelt/Nyheder/Medicin/2019/Maj/Op-mod-60000-genetiske-analyser-af-danske-patienter-paa-vej.aspx.
   Google Scholar
• Ministry of Health and Danish Regions. (2016). Personlig Medicin til gavn for patienterne. Klar diagnose, målrettet behandling, styrket forskning. National strategi for personlig medicin 2017–2020 [Personalized Medicine for the benefit of patients. Clear diagnosis, targeted treatment, enhanced research. National strategy for personalized medicine 2017–2020]. Copenhagen: Author.
   Google Scholar
• Morrison, M. (2012). Promissory futures and possible pasts: The dynamics of contemporary expectations in regenerative medicine. BioSocieties, 7(1), 3–22.
   Web of Science ®Google Scholar
• Murdoch, T. B., & Detsky, A. S. (2013). The inevitable application of big data to health care. Journal of the American Medical Association, 309(13), 1351–1352.
   PubMed Web of Science ®Google Scholar
• National Institutes of Health. (2018). All of Us research program. Protocol Version v.1.7. Retrieved from https://allofus.nih.gov/about/all-us-research-program-protocol.
   Google Scholar
• Prainsack, B. (2017). Personalized medicine. Empowered patients in the 21st century? New York: New York University Press.
   Google Scholar
• Reardon, J. (2017). The postgenomic condition. Ethics, justice & knowledge after the genome. Chicago: University of Chicago Press.
   Google Scholar
• Shendure, J., & Ji, H. (2008). Next generation DNA sequencing. Nature Biotechnology, 26(1), 1135–1145.
   PubMedGoogle Scholar
• Skøtt, O., Rasmussen, L. M., Kruse, T., Brunak, S., Nielsen, F. C., Kristiansen, K., … Gaub, J. (2015). Personlig medicin og individualiseret behandling: oplæg til en samlet dansk indsats [Personalized medicine and individualized treatment: A strategy for a united Danish effort]. Retrieved from https://www.regioner.dk/media/1281/personlig-medicin-og-individualiseret-behandling.pdf.
   Google Scholar
• Timmermans, S., & Buchbinder, M. (2012). Saving babies: The consequences of newborn genetic screening. Chicago: University of Chicago Press.
   Google Scholar
• Timmermans, S., Tietbohl, C., & Skaperdas, E. (2016). Narrating uncertainty: Variants of uncertain significance (VUS) in clinical exome sequencing. BioSocieties, 12(3), 439–458.
   Web of Science ®Google Scholar
• Tutton, R. (2014). Genomics and the reimagining of personalized medicine. Farnham, UK: Ashgate.
   Google Scholar